Discover
ACIU
AC Immune SA
2.38
2 x 1.68
2 x 2.76
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
2.27 -0.11 (4.62%)
| Ytd | -24.20% | |
| 1y | 20.20% |
2.15
day range
2.44
1.94
52 week range
4.00
| Open | 2.34 | Prev Close | 2.38 | Low | 2.15 | High | 2.44 | Mkt Cap | 242.22M |
| Vol | 686.01K | Avg Vol | 293.74K | EPS | -0.82 | P/E | N/A | Forward P/E | -10.72 |
| Beta | 1.28 | Short Ratio | 8.14 | Inst. Own | 28.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 2.67 | 200-d Avg | 2.98 | 1yr Est | 10.01 |
ACIU News
benzinga.com
AC Immune Announces Interim 12-Month Data From Its Phase 1b/2 ABATE Trial Of ACI-24 In Prodromal Alz
AC Immune SA (NASDAQ:ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeu
globenewswire.com
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer
benzinga.com
AC Immune Gets $4M Grant for Parkinson's Trial Extension
AC Immune SA (NASDAQ:ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeu